Herbal medicines today and the roots of modern pharmacology

Authors
Citation
P. Goldman, Herbal medicines today and the roots of modern pharmacology, ANN INT MED, 135(8), 2001, pp. 594-600
Citations number
51
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
ANNALS OF INTERNAL MEDICINE
ISSN journal
00034819 → ACNP
Volume
135
Issue
8
Year of publication
2001
Part
1
Pages
594 - 600
Database
ISI
SICI code
0003-4819(20011016)135:8<594:HMTATR>2.0.ZU;2-B
Abstract
The transformation of digitalis from a folk medicine, foxglove, to a modem drug, digoxin, illustrates principles of modern pharmacology that have help ed make drugs safer and more effective. Digitalis was improved because its preparation was standardized, first by bioassay and then by chemical method s; however, few of today's herbs are standardized by methods that can ensur e a consistent product and, hence, consistent safety and efficacy profiles. Many herbs have been evaluated in randomized, controlled trials, and sever al-St. John's wort and ginkgo, for example-are apparently effective. Yet, m any trials of herbs have limited value because of poor design, small sample s, and, above all, use of products of uncertain composition and consistency . The uncertain composition of many herbal products raises questions about their safety as does evidence indicating that herbs may have harmful intera ctions with prescription drugs. Such adverse effects of herbs are probably underreported. Meanwhile, systematic studies, such as those identifying adv erse reactions to drugs, are hindered because herbal preparations are not s tandardized-one: brand of St. John's wort, for example, will differ chemica lly from another-and, unlike for prescription drugs, there are no databases linking herb consumption to later medical problems. Since herbal medicines are regulated as dietary supplements, they are not subject to the premarke ting regulatory clearance required for drugs. The burden of proof, is on th e U.S. Food and Drug Administration to show a dietary supplement is unsafe, unlike for drugs, which cannot be approved until the manufacturer has demo nstrated safety and effectiveness.